Cannvas MedTech Inc. (“Cannvas” or the “Company”) (CSE:MTEC, Frankfurt:3CM), a leading business technology company in the cannabis space, continues to develop a substantial set of educational modules surrounding the consumption of cannabis-infused food and beverages for its Cannvas.Me educational platform. Leveraging the Company’s Health and Innovation Advisory Board, Medical Advisory Board and Education Advisory Panel, made up of members from industry and government institutions, Cannvas.Me will deliver comprehensive and credible information on the potential benefits of cannabis-infused edibles.

“We see immense opportunity for Cannvas.Me to become a leader in education on the subject of cannabis-infused food and beverage for medicinal and adult-use cannabis users, particularly with the emergence of major brands partnering with cannabis producers to explore this space,” said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc. “International companies are rushing to cannabis to create trendy and innovative consumer products and there is little credible information available to the public on whether these products will be beneficial to their lifestyle, a gap we expect to fill with our educational platform Cannvas.Me.”


As The Company continues to grow, recently expanding its team to 19 members and actively growing its partnership base with national and international organizations, it intends to harness the expertise of its staff, who bring with them years of experience working with food and beverage clients across Canada, to further guide content creation centered around cannabis-infused food and beverage. Cannvas recently hired Daniel Davidzon, who brings with him a wealth of experience in the foodservice industry including having helped grow Aroma Espresso Bar Canada from 20 to 46 locations in a four-year span.

“I look forward to sharing my expertise in foodservice and hospitality and staying on top of industry trends with the Cannvas.Me Health and Innovation Advisory Board, Medical Advisory Board and Education Advisory Panel to enrich the content our platform offers our users,” said Daniel Davidzon, Marketing Manager, Cannvas MedTech Inc. “We intend to stay at the forefront of the food and beverage industry not only in regards to cannabis-infused edibles but overall food trends to ensure we deliver credible information, quality recipes and the latest insights into the use of cannabis in edible or drinkable form.”

Cannvas.Me is a scalable and comprehensive solution for the global medical cannabis community offering interactive tools and physician-backed content to audiences wishing to learn about healthcare through cannabis. Its Cannvas Culinary educational modules encourage users to browse recipes and expert advice on cannabis consumption from accomplished chefs and cannabis advocates, dispelling the stigma that edibles only comprise candy, chocolate, cookies, or other sugar-filled desserts by showcasing simple and nutritious alternatives. Cannvas recently named Cody Lindsay, a veteran of the Canadian military, chef, cannabis advocate, and owner of The Wellness Soldier, as the featured expert for culinary cannabis on its learning platform Cannvas.Me

About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

For additional information:
www.cannvasmedtech.com

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted onwww.sedar.com.

For further information: Media Inquiries: media@cannvasmedtech.com; Investor Relations, ir@cannvasmedtech.com, 1-800-489-0116

Click here to connect with Cannvas MedTech Inc. (CSE:MTEC, Frankfurt:3CM) for an Investor Presentation.

Source: www.newswire.ca

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter fiscal 2021 ended December 31, 2020 before financial markets open on February 9, 2021.

Keep reading... Show less

NYSE | TSX: ACB

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000 . The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Keep reading... Show less

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000. The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Each Unit is comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

Keep reading... Show less

AMP German Cannabis Group Inc. (” AMP “) (CSE: XCX ), ( Frankfurt : C4T ) (ISIN: CA00176G1028) and Aphria Inc.’s (” Aphria “) (TSX: APHA ) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (” CC Pharma “), have entered into a strategic agreement (the ” Co-Promotion Agreement “) covering joint marketing of sales for Aphria brand medical cannabis products for the German market.

The Co-Promotion Agreement is a collaboration contract between AMP and CC Pharma to sell the Aphria medical cannabis brand in Germany . In addition, AMP will organize with the support of CC Pharma, “information events” in Germany to market Aphria branded products to doctors and pharmacists.

Keep reading... Show less

HempFusion Wellness Inc. ( TSX:CBD.U ) ( FWB:8OO ) (“ HempFusion ” or the “ Company ”) is pleased to announce that it has been included in two leading cannabis & hemp-derived CBD focused exchange-traded funds (“ ETFs ”), AdvisorShares Pure US Cannabis ETF ( NYSE:MSOS ) and AdvisorShares Pure Cannabis ETF ( NYSE:YOLO ).

AdvisorShares is a leading sponsor of actively managed ETFs. Pure US Cannabis ETF (MSOS) is the only US-listed ETF dedicated solely to US cannabis exposure, with over US$616,000,000 in assets under management (“ AUM ”). Pure Cannabis ETF (YOLO) was the first US-based actively managed ETF focused on the global cannabis industry. YOLO and MSOS endeavor to achieve long-term capital growth by investing in some of the largest foreign and domestic cannabis and hemp-derived CBD companies. The two AdvisorShares ETFs have a combined AUM of over US$880,000,000 as of January 22, 2021.

Keep reading... Show less